Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Eitemau Tebyg

• Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
  gan: Rohit Thummalapalli (17314483)
  Cyhoeddwyd: (2025)
• Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
  gan: Rohit Thummalapalli (17314483)
  Cyhoeddwyd: (2025)
• Supplementary Figure S11 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
  gan: Rohit Thummalapalli (17314483)
  Cyhoeddwyd: (2025)
• Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
  gan: Rohit Thummalapalli (17314483)
  Cyhoeddwyd: (2025)
• Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
  gan: Rohit Thummalapalli (17314483)
  Cyhoeddwyd: (2025)